Back to Compound Explorer
Delta-9-tetrahydrocannabinol (THC)
Clinical trialMechanism of Action
Partial CB1/CB2 agonist; responsible for psychoactive effects, analgesia, appetite stimulation, and antiemetic action
Research Notes
CannabisWestern
Extensive clinical evidence supports THC for neuropathic pain, chemotherapy-induced nausea, and appetite stimulation in wasting syndromes. Approved as dronabinol (Marinol) and nabilone (Cesamet) in multiple jurisdictions.
Found In 1 Herb
3D Molecular Structure
Cannabinoid
Drag to rotate · Click atoms to explore
Delta-9-tetrahydrocannabinol (THC)
CannabinoidBioactive phytochemical with therapeutic properties
Representative pattern: C₄H₂NO
Atoms
Carbon
Oxygen
Nitrogen
Hydrogen
Related Compounds (Cannabinoid)
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.